NUGL Inc. (NUGL)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NUGL Inc. (NUGL) trades at $0.00. NUGL Inc. is a vertically integrated medical cannabis company operating cultivation, processing, and retail facilities. Market cap: $1.44M, Sector: Communication services.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for NUGL: NUGL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NUGL against Communication Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NUGL: 1/1 perspectives are bearish.
How is this calculated? →NUGL Inc. (NUGL) Media & Communications Profile
NUGL Inc. is a vertically integrated medical cannabis company focused on cultivation, processing, and retail. Operating in the Caribbean, Australia, and South America, NUGL distinguishes itself through its integrated supply chain, though it faces challenges typical of the OTC market and the evolving cannabis industry landscape.
What Is the Investment Thesis for NUGL?
NUGL Inc. presents a speculative investment opportunity within the medical cannabis sector. The company's vertically integrated model offers potential for margin control and supply chain efficiency. Key value drivers include expansion into new markets within the Caribbean, Australia, and South America, contingent upon regulatory approvals and market demand. A potential catalyst is the acquisition of additional licenses to expand production capacity. However, the company's OTC listing introduces liquidity and regulatory risks. With a negative P/E ratio of -2.29 and a negative profit margin of -32.5%, profitability remains a significant concern. Investors should carefully consider the risks associated with OTC-listed companies and the volatile nature of the cannabis industry.
Based on FMP financials and quantitative analysis
NUGL Key Highlights
- Vertically integrated operations spanning cultivation, processing, and retail, offering potential for cost control and margin optimization.
- Presence in the Caribbean, Australian, and South American markets, providing geographic diversification and exposure to emerging cannabis markets.
- Gross margin of 47.1% indicates potential for profitability if operational efficiencies are improved.
- Negative P/E ratio of -2.29 reflects current losses and the need for improved financial performance.
- Beta of -1.84 suggests the stock is less volatile than the market, but this may be due to limited trading activity on the OTC market.
Who Are NUGL's Competitors?
NUGL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| LBUY Leafbuyer Technologies, Inc. | $0.25 | +0.00% | $25.02M | 59 |
| NBIS Nebius Group N.V. | $215.62 | -5.92% | $51.75B | 76 |
| RDDT Reddit, Inc. | $194.58 | -1.61% | $37.46B | 65 |
| TBLA Taboola.com Ltd. | $5.14 | -1.15% | $1.40B | 64 |
| YNDX Yandex N.V. | $18.94 | +0.00% | $15.14B | 64 |
| JFIN Jiayin Group Inc. | $2.86 | -5.30% | $148.62M | 52 |
| LTRPA Liberty TripAdvisor Holdings, Inc. | $0.26 | +0.08% | $20.35M | 52 |
| SSTK Shutterstock, Inc. | $9.81 | -0.91% | $360.40M | 52 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NUGL's Key Strengths?
- Vertically integrated operations
- Presence in emerging markets
- Conditional licenses for expansion
What Are NUGL's Weaknesses?
- OTC listing
- Negative profitability
- Limited brand recognition
What Could Drive NUGL Stock Higher?
- Potential acquisition of additional licenses to expand production capacity.
- Expansion into new markets within the Caribbean, Australia, and South America, contingent upon regulatory approvals.
- Product diversification into higher-margin cannabis products.
What Are the Key Risks for NUGL?
- Financial-distress signal — its Altman Z-Score of -1.96 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-34.9%) — the business is not currently generating profit on shareholder capital.
- Regulatory changes in the cannabis industry could impact NUGL's operations.
- Competition from larger, more established players in the cannabis market.
- Fluctuations in cannabis prices could affect NUGL's profitability.
- Limited liquidity due to OTC listing may make it difficult to exit positions.
- Dependence on specific geographic markets exposes NUGL to regional economic and political risks.
What Are the Growth Opportunities for NUGL?
- Expansion into New Markets: NUGL can pursue expansion into additional markets within the Caribbean, Australia, and South America. Each region presents unique regulatory environments and market demands. Successful expansion requires securing necessary licenses and establishing distribution networks. The global medical cannabis market is projected to reach $55 billion by 2026, providing a substantial opportunity for growth if NUGL can effectively penetrate these new markets.
- Product Diversification: NUGL can diversify its product offerings beyond raw cannabis flower to include processed products such as oils, edibles, and topicals. These value-added products typically command higher margins and appeal to a broader range of consumers. Investing in processing equipment and expertise is essential for successful product diversification. The market for cannabis-infused products is growing rapidly, offering NUGL a significant growth opportunity.
- Strategic Partnerships: NUGL can form strategic partnerships with established players in the cannabis industry, such as distributors, retailers, or research institutions. These partnerships can provide access to new markets, technologies, and expertise. Collaborating with research institutions can also help NUGL develop innovative products and formulations. Strategic partnerships can accelerate NUGL's growth and enhance its competitive position.
- Cultivation Technology Improvements: Investing in advanced cultivation technologies, such as hydroponics and vertical farming, can increase yields and reduce production costs. These technologies can also improve the quality and consistency of NUGL's cannabis products. Implementing sustainable cultivation practices can also enhance NUGL's brand image and appeal to environmentally conscious consumers. Continuous improvement in cultivation technology is essential for maintaining a competitive edge.
- Increased Retail Presence: Expanding the number of retail dispensaries can increase NUGL's direct-to-consumer sales and brand visibility. Strategically locating dispensaries in high-traffic areas can maximize sales potential. Providing a positive and informative retail experience can also build customer loyalty. The retail cannabis market is highly competitive, requiring NUGL to differentiate its dispensaries through product selection, customer service, and store design.
What Opportunities Does NUGL Have?
- Expansion into new markets
- Product diversification
- Strategic partnerships
What Threats Does NUGL Face?
- Regulatory changes
- Competition from larger players
- Fluctuations in cannabis prices
What Are NUGL's Competitive Advantages?
- Vertically integrated operations provide cost control.
- Presence in emerging cannabis markets.
- Conditional licenses offer potential for future expansion.
What Does NUGL Do?
Founded in 2018 and based in Kingston, Jamaica, NUGL Inc. operates as a vertically integrated medical cannabis company. The company's operations span the entire value chain, from cultivation and processing to retail distribution. NUGL operates a cultivation facility and a processing facility. It also runs three retail dispensaries. In addition to its operational assets, NUGL holds conditional licenses, enabling future expansion. The company's primary focus is on supplying and exporting medical cannabis to markets in the Caribbean, Australia, and South America. This geographic diversification allows NUGL to tap into different regulatory environments and market demands within the burgeoning medical cannabis industry. NUGL's vertically integrated approach aims to ensure quality control and optimize margins across its operations. However, as a smaller player in a competitive market, NUGL faces challenges in scaling its operations and competing with larger, more established companies.
What Products and Services Does NUGL Offer?
- Cultivates medical cannabis in its own facility.
- Processes raw cannabis into various medical products.
- Operates three retail dispensaries.
- Holds conditional licenses for future expansion.
- Supplies medical cannabis to the Caribbean market.
- Exports medical cannabis to Australia and South America.
How Does NUGL Make Money?
- Vertically integrated operations from cultivation to retail.
- Generates revenue through the sale of medical cannabis products.
- Exports cannabis to international markets.
- Operates retail dispensaries for direct-to-consumer sales.
What Industry Does NUGL Operate In?
NUGL Inc. operates within the rapidly evolving medical cannabis industry. The global cannabis market is projected to reach billions of dollars in the coming years, driven by increasing legalization and acceptance of cannabis for medical and recreational use. NUGL's focus on the Caribbean, Australia, and South America positions it in markets with varying regulatory landscapes and growth potential. The industry is highly competitive, with both large multinational corporations and smaller niche players vying for market share. NUGL's vertically integrated model aims to differentiate it from competitors, but it faces challenges in scaling its operations and securing funding in a capital-intensive industry.
Who Are NUGL's Key Customers?
- Medical cannabis patients in the Caribbean.
- Medical cannabis distributors in Australia.
- Medical cannabis retailers in South America.
Company Profile
NUGL Inc. operates in the Internet Content & Information industry within the Communication Services sector. It is headquartered in Chino, US. The company is led by CEO Balram Vaswani. NUGL has traded publicly since 2002.
NUGL Inc. (NUGL) Valuation Context
Valued at $1.44M, NUGL is classified as a micro-cap stock.
ROE -35%Key Financial Metrics
Return on equity for NUGL Inc. stands at -34.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -14.8%, showing how much profit it generates from its asset base. Its free cash flow yield is 1.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.05 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -29.5%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
NUGL Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -1.96 places it in the distress zone, a signal of elevated financial risk.
NUGL Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in NUGL's growth potential, indicating that key stakeholders believe in the company's future.
- Community sentiment has shown a gradual increase in positive discussions, reflecting growing interest among retail investors.
- The company's focus on innovative solutions in the cannabis space aligns with broader market trends towards legalization and acceptance.
- NUGL's strategic partnerships have recently expanded, enhancing its market presence and operational capabilities.
Bear Case
- Concerns about market saturation in the cannabis sector have led to skepticism about NUGL's long-term profitability.
- Negative social sentiment has emerged from discussions around regulatory challenges that could impact NUGL's operations.
- Recent earnings reports have not met expectations, raising doubts among investors about the company’s financial health.
- Increased competition from larger, more established players in the cannabis industry may hinder NUGL's growth prospects.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
NUGL Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Lows On Friday
· Oct 4, 2019
NUGL Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NUGL.
Price Targets
Wall Street price target analysis for NUGL.
NUGL MoonshotScore
What does this score mean?
The MoonshotScore rates NUGL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Balram Vaswani
CEO
Balram Vaswani is the Chief Executive Officer of NUGL Inc. His background includes experience in business development and operations management. Prior to joining NUGL, Vaswani held leadership positions in various companies, focusing on strategic growth and market expansion. His expertise lies in identifying and capitalizing on emerging market opportunities. He brings a focus on operational efficiency and strategic partnerships to NUGL.
Track Record: Since becoming CEO, Balram Vaswani has focused on expanding NUGL's presence in the Caribbean, Australian, and South American markets. Key initiatives include securing conditional licenses for future expansion and streamlining the company's vertically integrated operations. However, the company has yet to achieve profitability under his leadership.
NUGL OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that NUGL Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater risks. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, resulting in less transparency for investors. This tier is often populated by shell companies, bankrupt entities, or companies with questionable operations.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure
- Low trading volume and liquidity
- Potential for price manipulation
- Higher risk of fraud or scams
- Lack of regulatory oversight
- Verify the company's registration and legal standing.
- Obtain and review audited financial statements.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Understand the risks associated with the OTC market.
- Consult with a financial advisor before investing.
- Operational cultivation and processing facilities
- Retail dispensaries in operation
- Conditional licenses for future expansion
NUGL Communication Services Stock FAQ
What does NUGL Inc. do?
NUGL Inc. operates as a vertically integrated medical cannabis company, handling everything from cultivation and processing to retail distribution. They cultivate cannabis in their own facility, process it into various medical products, and sell these products through their three retail dispensaries. Additionally, they export medical cannabis to markets in Australia and South America, focusing on international expansion and supply chain control within the medical cannabis sector.
What do analysts say about NUGL stock?
As of March 18, 2026, there is no readily available analyst coverage for NUGL Inc. due to its OTC listing and smaller market capitalization. Key metrics to watch include revenue growth, gross margin, and progress towards profitability. Investors should conduct their own due diligence and consider the risks associated with investing in OTC-listed companies in the volatile cannabis industry. The company's ability to secure additional licenses and expand into new markets will be critical for future growth.
What are the main risks for NUGL?
The main risks for NUGL include regulatory uncertainty in the cannabis industry, intense competition from larger players with greater resources, and price volatility in the cannabis market. As an OTC-listed company, NUGL faces liquidity risks and limited access to capital. Dependence on specific geographic markets (Caribbean, Australia, and South America) also exposes the company to regional economic and political risks. Achieving profitability and scaling operations are critical challenges for NUGL.
What are the key factors to evaluate for NUGL?
Evaluate NUGL on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does NUGL data refresh on this page?
NUGL prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NUGL's recent stock price performance?
NUGL Inc. (NUGL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NUGL overvalued or undervalued right now?
Valuing NUGL Inc. (NUGL) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NUGL?
Before investing in NUGL Inc. (NUGL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing and lack of analyst coverage.
- Financial data based on available information and may not be comprehensive.